The latest round in an ongoing dispute between Boston Scientific (Natick, Massachusetts) and Cordis (Miami Lakes, Florida), a Johnson & Johnson (J&J New Brunswick, New Jersey) company, could put the so-called stent wars to rest – for a while at least. Cordis reported the companies reached a settlement and that Boston Scientific was slated to pay $1.73 billion to J&J. (Medical Device Daily)